FDA Approves ZENATANE — BluePoint Laboratories

# FDA Approves BluePoint Laboratories' Generic Isotretinoin (Zenatane) BluePoint Laboratories received FDA approval for Zenatane (isotretinoin) oral formulation under ANDA 202099, adding another generic competitor to the isotretinoin market and potentially increasing price competition for this acne treatment. The approval expands treatment options for severe acne patients while likely putting downward pressure on pricing for branded and previously approved generic versions.